Synergistic effects of PPARγ ligands and retinoids in cancer treatment

PPAR Research

Volumn , Issue , 2008, Pages

  Shimizu, Masahito ^a   Moriwaki, Hisataka ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER GROWTH; CANCER THERAPY; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLORECTAL CANCER; GENE EXPRESSION; GENE TARGETING; HUMAN; PHOSPHORYLATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; TUMOR GROWTH;

EID: 45349092527     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2008/181047     Document Type: Review

References (91)

1. Lefebvre P., Chinetti G., Fruchart J.-C., Staels B.
2. Lemberger T., Desvergne B., Wahli W., Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology Annual Review of Cell and Developmental Biology 1996 12 335 363
3. Chinetti G., Fruchart J.-C., Staels B.
4. Michalik L., Desvergne B., Wahli W.
5. Grommes C., Landreth G. E., Heneka M. T.
6. Sertznig P., Seifert M., Tilgen W., Reichrath J.
7. Demetri G. D., Fletcher C. D. M., Mueller E., Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor- γ ligand troglitazone in patients with liposarcoma Proceedings of the National Academy of Sciences of the United States of America 1999 96 7 3951 3956
8. Burstein H. J.
9. Kulke M. H., Demetri G. D., Sharpless N. E., A phase II study of troglitazone, an activator of the PPAR γ receptor, in patients with chemotherapy-resistant metastatic colorectal cancer Cancer Journal 2002 8 5 395 399
10. Smith M. R.
11. Yamazaki K., Shimizu M.
12. Chambon P., A decade of molecular biology of retinoic acid receptors The FASEB Journal 1996 10 9 940 954
13. Mangelsdorf D. J., Thummel C., Beato M., The nuclear receptor superfamily: the second decade Cell 1995 83 6 835 839
14. Kliewer S. A., Umesono K., Noonan D. J., Heyman R. A., Evans R. M., Convergence of 9- cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors Nature 1992 358 6389 771 774
15. Tontonoz P., Singer S., Forman B. M., Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor Proceedings of the National Academy of Sciences of the United States of America 1997 94 1 237 241
16. Szanto A., Narkar V., Shen Q., Uray I. P., Davies P. J. A., Nagy L.
17. Bruck N., Bastien J., Bour G., Phosphorylation of the retinoid X receptor at the omega loop, modulates the expression of retinoic-acid-target genes with a promoter context specificity Cellular Signalling 2005 17 10 1229 1239
18. Gianní M., Tarrade A., Nigro E. A., Garattini E., Rochette-Egly C.
19. Bastien J., Adam-Stitah S., Plassat J. L., Chambon P., Rochette-Egly C., The phosphorylation site located in the A region of retinoic X receptor α is required for the antiproliferative effect of retinoic acid (RA) and the activation of RA target genes in F9 cells Journal of Biological Chemistry 2002 277 32 28683 28689
20. Rochette-Egly C.
21. Lee H.-Y., Suh Y.-A., Robinson M. J., Stress pathway activation induces phosphorylation of retinoid X receptor Journal of Biological Chemistry 2000 275 41 32193 32199
22. Matsushima-Nishiwaki R., Okuno M., Adachi S., Phosphorylation of retinoid X receptor α at serine 260 impairs its metabolism and function in human hepatocellular carcinoma Cancer Research 2001 61 20 7675 7682
23. Solomon C., White J. H., Kremer R., Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3- dependent signal transduction by phosphorylating human retinoid X receptor α Journal of Clinical Investigation 1999 103 12 1729 1735
24. Altucci L.
25. Matsushima-Nishiwaki R., Okuno M.
26. Adachi S., Okuno M., Matsushima-Nishiwaki R., Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma Hepatology 2002 35 2 332 340
27. Yoshimura K., Muto Y., Shimizu M.
28. Moriwaki H., Shimizu M., Okuno M., Nishiwaki-Matsushima R., Chemoprevention of liver carcinogenesis with retinoids: basic and clinical aspects Hepatology Research 2007 37 supplement 2 S299 S302
29. Kanemura N., Tsurumi H., Okuno M., Matsushima-Nishiwaki R., Shimizu M., Moriwaki H.
30. Lattuada D., Viganó P., Mangioni S., Accumulation of retinoid X receptor- α in uterine leiomyomas is associated with a delayed ligand-dependent proteasome-mediated degradation and an alteration of its transcriptional activity Molecular Endocrinology 2007 21 3 602 612
31. Adam-Stitah S., Penna L., Chambon P., Rochette-Egly C.
32. Egea P. F., Mitschler A., Rochel N., Ruff M., Chambon P., Moras D.
33. Macoritto M., Nguyen-Yamamoto L., Huang D. C., Phosphorylation of the human retinoid X receptor α at serine 260 impairs coactivator(s) recruitment and induces hormone resistance to multiple ligands The Journal of Biological Chemistry 2008 283 8 4943 4956
34. Yamada Y., Shidoji Y., Fukutomi Y., Positive and negative regulations of albumin gene expression by retinoids in human hepatoma cell lines Molecular Carcinogenesis 1994 10 3 151 158
35. Araki H., Shidoji Y., Yamada Y., Moriwaki H., Muto Y., Retinoid agonist activities of synthetic geranyl geranoic acid derivatives Biochemical and Biophysical Research Communications 1995 209 1 66 72
36. Muto Y., Moriwaki H., Antitumor activity of vitamin A and its derivatives Journal of the National Cancer Institute 1984 73 6 1389 1393
37. Nakamura N., Shidoji Y., Yamada Y., Hatakeyama H., Moriwaki H., Muto Y., Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, HuH-7 Biochemical and Biophysical Research Communications 1995 207 1 382 388
38. Nakamura N., Shidoji Y., Moriwaki H., Muto Y., Apoptosis in human hepatoma cell line induced by 4,5-didehydro geranylgeranoic acid (acyclic retinoid) via down-regulation of transforming growth factor- α Biochemical and Biophysical Research Communications 1996 219 1 100 104
39. Suzui M., Masuda M., Lim J. T. E., Albanese C., Pestell R. G., Weinstein I. B., Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21CIP1 and inhibition of expression of cyclin D1 Cancer Research 2002 62 14 3997 4006
40. Suzui M., Shimizu M., Masuda M., Lim J. T. E., Yoshimi N., Weinstein I. B.
41. Shimizu M., Suzui M., Deguchi A., Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells Clinical Cancer Research 2004 10 19 6710 6721
42. Kanamori T., Shimizu M.
43. Shimizu M., Suzui M., Deguchi A., Lim J. T. E., Weinstein I. B.
44. Tsurumi H., Tojo A., Takahashi T., Differentiation induction of human promyelocytic leukemia cells by acyclic retinoid (polyprenoic acid) International Journal of Hematology 1993 59 1 9 15
45. Muto Y., Moriwaki H., Ninomiya M., Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma The New England Journal of Medicine 1996 334 24 1561 1568
46. Muto Y., Moriwaki H., Saito A., Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma The New England Journal of Medicine 1999 340 13 1046 1047
47. Takai K., Okuno M., Yasuda I., Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma: updated analysis of the long-term follow-up data Intervirology 2005 48 1 39 45
48. Konopleva M., Elstner E., McQueen T. J., Peroxisome proliferator- activated receptor γ and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias Molecular Cancer Therapeutics 2004 3 10 1249 1262
49. Lee Y.-R., Yu H.-N., Noh E.-M., Peroxisome proliferator-activated receptor γ and retinoic acid receptor synergistically up-regulate the tumor suppressor PTEN in human promyeloid leukemia cells International Journal of Hematology 2007 85 3 231 237
50. Ray D. M., Bernstein S. H., Phipps R. P.
51. Hirase N., Yanase T.
52. Crowe D. L., Chandraratna R. A., A retinoid X receptor (RXR)-selective retinoid reveals that RXR- α is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands Breast Cancer Research 2004 6 5 R546 R555
53. Mehta R. G.
54. Elstner E., Williamson E. A., Zang C., Novel therapeutic approach: ligands for PPAR γ and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells Breast Cancer Research and Treatment 2002 74 2 155 165
55. Rubin G. L., Duong J. H., Clyne C. D., Ligands for the peroxisomal proliferator-activated receptor γ and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose Endocrinology 2002 143 8 2863 2871
56. Saidi S. A.
57. James S. Y., Lin F., Kolluri S. K., Dawson M. I., Zhang X.-K.
58. Cesario R. M.
59. Yang W., Rachez C., Freedman L. P., Discrete roles for peroxisome proliferator-activated receptor γ and retinoid X receptor in recruiting nuclear receptor coactivators Molecular and Cellular Biology 2000 20 21 8008 8017
60. Tsao W.-C., Wu H.-M., Chi K.-H., Chang Y.-H., Lin W.-W.
61. Park E. Y., Cho I. J., Kim S. G.
62. Sarraf P., Mueller E., Jones D., Differentiation and reversal of malignant changes in colon cancer through PPAR γ Nature Medicine 1998 4 9 1046 1052
63. Kitamura S., Miyazaki Y., Shinomura Y., Kondo S., Kanayama S., Matsuzawa Y., Peroxisome proliferator-activated receptor γ induces growth arrest and differentiation markers of human colon cancer cells Japanese Journal of Cancer Research 1999 90 1 75 80
64. Shimada T., Kojima K., Yoshiura K., Hiraishi H., Terano A., Characteristics of the peroxisome proliferator activated receptor γ (PPAR γ) ligand induced apoptosis in colon cancer cells Gut 2002 50 5 658 664
65. Tanaka T., Kohno H., Yoshitani S.-I., Ligands for peroxisome proliferator-activated receptors α and γ inhibit chemically induced colitis and formation of aberrant crypt foci in rats Cancer Research 2001 61 6 2424 2428
66. Yang W.-L., Frucht H., Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells Carcinogenesis 2001 22 9 1379 1383
67. Gupta R. A., DuBois R. N.
68. Desreumaux P.
69. Castellone M. D., Teramoto H., Gutkind J. S.
70. Eisinger A. L.
71. Lu D.
72. Dubuquoy L., Dharancy S., Nutten S., Pettersson S., Auwerx J., Desreumaux P.
73. Girnun G. D., Naseri E., Vafai S. B., Synergy between PPAR γ ligands and platinum-based drugs in cancer Cancer Cell 2007 11 5 395 406
74. Akiyama S.-I.
75. Fulzele S. V., Chatterjee A., Shaik M. S., Jackson T., Ichite N., Singh M.
76. Copland J. A.
77. Budman D. R.
78. Fajas L., Egler V., Reiter R., The retinoblastoma-histone deacetylase 3 complex inhibits PPAR γ and adipocyte differentiation Developmental Cell 2002 3 6 903 910
79. Annicotte J.-S., Iankova I., Miard S., Peroxisome proliferator-activated receptor γ regulates E-cadherin expression and inhibits growth and invasion of prostate cancer Molecular and Cellular Biology 2006 26 20 7561 7574
80. Emmans V. C., Rodway H. A., Hunt A. N., Lillycrop K. A.
81. Freudlsperger C.
82. Liu H., Zang C., Fenner M. H., Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPAR α / γ ligand TZD18 Blood 2006 107 9 3683 3692
83. Zang C., Liu H., Waechter M., Dual PPAR α / γ ligand TZD18 either alone or in combination with imatinib inhibits proliferation and induces apoptosis of human CML cell lines Cell Cycle 2006 5 19 2237 2243
84. Lee S. Y., Hur G. Y., Jung K. H., PPAR- γ agonist increase gefitinib's antitumor activity through PTEN expression Lung Cancer 2006 51 3 297 301
85. Pignatelli M., Cortés-Canteli M., Lai C., Santos A., Perez-Castillo A., The peroxisome proliferator-activated receptor γ is an inhibitor of ErbBs activity in human breast cancer cells Journal of Cell Science 2001 114 22 4117 4126
86. Burns K. A., Vanden Heuvel J. P.
87. Adams M., Reginato M. J., Shao D., Lazar M. A., Chatterjee V. K., Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site Journal of Biological Chemistry 1997 272 8 5128 5132
88. Hu E., Kim J. B., Sarraf P., Spiegelman B. M., Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR γ Science 1996 274 5295 2100 2103
89. Camp H. S., Tafuri S. R.
90. Floyd Z. E., Stephens J. M.
91. Hedvat M., Jain A., Carson D. A., Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPAR γ Cancer Cell 2004 5 6 565 574